Home
About
Overview
Sharing Data
ORCID
Help
History (14)
A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice.
Therapeutics: Gene Therapy for Alpha-1 Antitrypsin Deficiency.
Intrathecal gene therapy for neurologic disease in humans.
From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC).
Tailoring tyrosine kinase inhibitors to fit the lung cancer genome.
See All 14 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tailoring tyrosine kinase inhibitors to fit the lung cancer genome.
Looyenga BD, Cherni I, Mackeigan JP, Weiss GJ. Tailoring tyrosine kinase inhibitors to fit the lung cancer genome. Transl Oncol. 2011 Apr 01; 4(2):59-70.
View in:
PubMed
authors with profiles
Glen Weiss MD, MBA